| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/18/2001 | CA2378179A1 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | CA2378170A1 Increased throughput analysis of small compounds using multiple temporally spaced injections |
| 01/18/2001 | CA2378097A1 Induction of a th1-like response in vitro |
| 01/18/2001 | CA2377938A1 Methods and compositions for directed cloning and subcloning using homologous recombination |
| 01/18/2001 | CA2377918A1 Compositions and methods for promoting nerve regeneration |
| 01/18/2001 | CA2377228A1 E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death |
| 01/18/2001 | CA2348448A1 Nucleotide sequences for the tal gene |
| 01/18/2001 | CA2348365A1 Nucleotide sequences which code for the opca gene |
| 01/18/2001 | CA2339422A1 Detection of anti-hepatitis b drug resistance |
| 01/17/2001 | EP1069190A2 Method for amplification of RNA |
| 01/17/2001 | EP1069189A2 Genotyping biallelic markers |
| 01/17/2001 | EP1069184A1 Human anion transporter gene implicated in Salla disease and lysosomal sialic acid transport |
| 01/17/2001 | EP1068799A2 Biological models capable of exhibiting secondary disease manifestations |
| 01/17/2001 | EP1068536A1 Improved blood coagulation test |
| 01/17/2001 | EP1068533A2 Method of measuring bone resorption rate |
| 01/17/2001 | EP1068530A1 Diagnostic for metastatic prostate cancer |
| 01/17/2001 | EP1068528A2 Tumor tissue microarrays for rapid molecular profiling |
| 01/17/2001 | EP1068527A2 Rapid method for detecting micro-organisms and evaluating antimicrobial activity |
| 01/17/2001 | EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof |
| 01/17/2001 | EP1068361A1 Diagnosis of multiple sclerosis and other demyelinating diseases |
| 01/17/2001 | EP1068360A1 Method and device for quantifying dna and rna |
| 01/17/2001 | EP1068359A1 Electrochemical sensor using intercalative, redox-active moieties |
| 01/17/2001 | EP1068358A1 Oligonucleotides containing pyrazolo 3,4-d]pyrimidines for hybridization and mismatch discrimination |
| 01/17/2001 | EP1068357A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 01/17/2001 | EP1068356A1 Addressable protein arrays |
| 01/17/2001 | EP1068355A2 Oligonucleotide probes for detecting enterobacteriaceae and quinolone-resistant enterobacteriaceae |
| 01/17/2001 | EP1068354A2 Biallelic markers |
| 01/17/2001 | EP1068353A2 Coding sequence polymorphisms in vascular pathology genes |
| 01/17/2001 | EP1068352A2 Nucleic acid detection method |
| 01/17/2001 | EP1068351A2 A method for obtaining a plant with a genetic lesion in a gene sequence |
| 01/17/2001 | EP1068350A1 Directed antisense libraries |
| 01/17/2001 | EP1068349A1 Reference material for nucleic acid amplification |
| 01/17/2001 | EP1068348A1 Method of preparing polypeptides in cell-free system and device for its realization |
| 01/17/2001 | EP1068347A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 01/17/2001 | EP1068336A2 Membranemetalloprotease nepii |
| 01/17/2001 | EP1068328A1 Treatment and diagnosis of staphylococcal infections |
| 01/17/2001 | EP1068323A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 01/17/2001 | EP1068321A2 A interleukin-1 receptor antagonist and uses thereof |
| 01/17/2001 | EP1068315A2 Therapeutic agent for ngf |
| 01/17/2001 | EP1068312A2 5' ests and encoded human proteins |
| 01/17/2001 | EP1068310A1 Method for screening compounds capable of inhibiting fixing between the transcription factor of stat1 and the transcription factor of usf1 |
| 01/17/2001 | EP1068305A2 High throughput dna sequencing vector |
| 01/17/2001 | EP1068297A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency |
| 01/17/2001 | EP1068295A1 Cell differentiation/proliferation and maintenance factor and uses thereof |
| 01/17/2001 | EP1068238A1 An integrin heterodimer and a subunit thereof |
| 01/17/2001 | EP1068237A1 T cell receptor expression cassette |
| 01/17/2001 | EP1068236A1 Human oxidized ldl receptor |
| 01/17/2001 | EP1068231A2 Human nucleic acid sequences of normal ovary tissue |
| 01/17/2001 | EP1068218A2 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 01/17/2001 | EP1068217A1 Novel molecules of the card-related protein family and uses thereof |
| 01/17/2001 | EP1068216A2 Libraries of oligomers labelled with different tags |
| 01/17/2001 | EP1068155A1 Substrate for array printing |
| 01/17/2001 | EP1067963A1 Hiv-specific cytotoxic t-cell responses |
| 01/17/2001 | EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders |
| 01/17/2001 | EP1067893A2 Human galactosyl transferases |
| 01/17/2001 | EP1067879A1 Method for inhibiting thrombosis in a patient whose blood is subjected to extracorporeal circulation |
| 01/17/2001 | EP0948408A4 Microfabricated sleeve devices for chemical reactions |
| 01/17/2001 | EP0882226A4 Electrochemical method |
| 01/17/2001 | EP0792374B1 Self-quenching fluorescence probe and method |
| 01/17/2001 | EP0788555B1 Methods of analysis and manipulation of dna utilizing mismatch repair systems |
| 01/17/2001 | EP0610396B1 Fingerprinting bacterial strains using repetitive dna sequence amplification |
| 01/17/2001 | EP0539495B1 Device and method for measuring hdl-cholesterol employing precipitation on a solid-phase |
| 01/17/2001 | CN1280673A Improved electrochemical biosensor test strip |
| 01/17/2001 | CN1280623A Method and compositions useful for activation of silent transgenes |
| 01/17/2001 | CN1280620A Antigen protein and nucleic acid coding for said protein |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280618A Protein involved in abscisic acid signalling |
| 01/17/2001 | CN1280617A TSA 305 gene |
| 01/17/2001 | CN1280614A Recombinational cloning using nucleic acids having recombinatin sites |
| 01/17/2001 | CN1280613A Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 01/17/2001 | CN1280611A Method and compositions for binding hematopoietic stem cells |
| 01/17/2001 | CN1280195A Method for producing biological chip |
| 01/17/2001 | CN1280194A Culture fluid for T-lymphocytes |
| 01/17/2001 | CN1280193A Cell dyeing method |
| 01/17/2001 | CN1280192A Cell dyeing liquid |
| 01/17/2001 | CN1060781C Phosphonomonoester nucleic acids, process for treir preparation, and their use |
| 01/16/2001 | US6175060 Transgenic plant having a cell transformed by a vector including dna which activates transcription of a structural gene under conditions of phosphate-starvation; recombinant production of proteins; disease resistance |
| 01/16/2001 | US6175002 Double stranded nucleic acid adaptor having a 3' blocked protuding strand; prevents self-ligation for more efficient and reliable methods |
| 01/16/2001 | US6175000 Nucleic acids encoding human trithorax protein |
| 01/16/2001 | US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 01/16/2001 | US6174870 Antisense oligonucleotide inhibition of papillomavirus |
| 01/16/2001 | US6174868 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 01/16/2001 | US6174733 Detection of pathogens using a column device with a sample containing a control |
| 01/16/2001 | US6174729 Accurate, simple method by applying protein solution to porous support, solution diffuses in presence of detergent and salt and/or acid to form uniform spot, measuring size of spot, comparing to standard |
| 01/16/2001 | US6174722 Drug screening by using dna template of target sequence under control of regulatory sequence, mixing with nuclear extract and labeled nucleotide, mixing with candidate, binding labeled transcript to solid matrix, and measuring amount |
| 01/16/2001 | US6174709 Accumulation of nucleotide sequences; forming a mixture of sample and preferential oligonucleotides, accumulating target nucleotide sequences by polymerase chain reaction |
| 01/16/2001 | US6174700 Purification of a polypeptide compound having a polysaccharide binding domain by affinity phase separation |
| 01/16/2001 | US6174698 Applying precise, focused energy to photoactivate; testing fragility |
| 01/16/2001 | US6174696 Method for the determination of homocysteine |
| 01/16/2001 | US6174695 Epoxide hydrolase inhibitor methods |
| 01/16/2001 | US6174694 Phosphorylation of serine containing substrate; incubate substrate with adenosine triphosphate and a enzymatic protein, monitor the amount of phosphorylation |
| 01/16/2001 | US6174693 Immunological assay for protein activity |
| 01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
| 01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
| 01/16/2001 | US6174690 Detecting sodium channel modulators; incubate cells expressing sodium channels with indicator and monitor suspension for color, change in color is indicative of activation by modulators |
| 01/16/2001 | US6174684 CYP3A4 NFSE variant and methods of use therefore |
| 01/16/2001 | US6174683 Immobilization of biomolecular probes by using derivatized polyurethane-based hydrogels; stability, genetic engineering |
| 01/16/2001 | US6174681 Method and probe set for detecting cancer |
| 01/16/2001 | US6174680 Hybridization of dna sequences to form duplex; removal of spontaneous aldehydes; reacting with detectable hydrazine oxyamine, or amine compound; repair |
| 01/16/2001 | US6174679 CIF150/hTAFII150 is necessary for cell cycle progression |